Physician profile
Kacey A Combs
NPI 1376176081
$627.91
in general payments reported to CMS, 2019-2025
15 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.64 · 2022: $65.99 · 2023: $213 · 2024: $134 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $173.96 | 2023-2025 | |
| Shield Therapeutics INC | $62.61 | 2024 | |
| Organon LLC | $56.22 | 2022-2023 | Nexplanon |
| Abbvie INC. | $51.77 | 2022-2025 | |
| Hologic Sales and Service, LLC | $43.86 | 2023-2025 | Thinprep 2000 Processor, Aptima, Omni Hysteroscope |
| Exeltis, USA INC. | $37.79 | 2023-2025 | Slynd |
| Coopersurgical, INC. | $31.69 | 2022-2023 | Paragard T 380a |
| Baxter Healthcare | $27.52 | 2023 | Tisseel |
| Integra Lifesciences Corporation | $27.42 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Astellas Pharma US INC | $22.20 | 2023 | Veozah |
| Sumitomo Pharma America, INC. | $21.85 | 2024 | Myfembree |
| Novo Nordisk INC | $19.64 | 2021 | |
| Avanos Medical | $18.86 | 2025 | On-Q Pump and Accessories |
| Daiichi Sankyo INC. | $16.37 | 2023 | Injectafer |
| Sage Therapeutics, LLC | $16.15 | 2025 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kacey Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.